PRICE T ROWE OTC FUND INC
485B24E, 1995-02-24
Previous: PRICE T ROWE OTC FUND INC, 24F-2NT, 1995-02-24
Next: PAINE WEBBER GROUP INC, 8-K/A, 1995-02-24




SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549

FORM N-1A
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

Post-Effective Amendment No. 88                                              
*

T. ROWE PRICE OTC FUND, INC.
(Exact Name of Registrant as Specified in Charter)

100 East Pratt Street, Baltimore, Maryland  21202
(Address of Principal Executive Offices)

Telephone Number: 410-547-2000

Henry H. Hopkins
100 East Pratt Street
Baltimore, Maryland 21202
(Name and Address of Agent for Service)

<PAGE>
Approximate Date of Proposed Public Offering

It is proposed that this filing will become effective:
            X        immediately upon filing pursuant to paragraph (b)
                     on (date) pursuant to paragraph (b)
                     60 days after filing pursuant to paragraph (a)
                     on (date) pursuant to paragraph (a) of Rule 485

     Pursuant to Section 24f-2 of the Securities Act of 1933, the
Registrant has registered an indefinite number of securities and intends
to file a 24f-2 Notice by February 28, 1995.                                 
*

CALCULATION OF REGISTRATION FEE UNDER THE SECURITIES ACT OF 1933

                                     Proposed        Proposed
                                      Maximum         Maximum
                      Amount         Offering        Aggregate     Amount of
Title of Securities    Being           Price         Offering    Registration
Being Registered    Registered       Per Unit          Price         Fee      

                                                                   
Capital Stock of $.50                Varying prices calculated           
par value per share    411,091       as set forth in prospectus        None  
*

                                                                   
Capital Stock of $.50                          
par value per share      20,626                                        $100  
*
                                                                             
*The calculation of the registration fee was made pursuant to Rule 24e-2 and
was based upon an offering price of $14.06 per share, equal to the net asset 
*
value as of the close of business on February 9, 1995 pursuant to Rule       
*
457(c).  The total number of shares redeemed during this fiscal year ended 
December 31, 1994 amounted to 2,695,301 shares.  Of this number of           
*
shares, -0- shares have been used for reduction pursuant to paragraph (a) of
Rule 24e-2 in all previous filings of post-effective amendments during the 
current year, and 2,284,210 shares have been used for reduction pursuant     
*
to paragraph (c) of Rule 24f-2 in all previous filings during the current
year.  411,091 shares of the redeemed shares for the fiscal year ended       
*
December 31, 1994 are being used for the reduction in the post-effective     
*
amendment being filed herein.

<PAGE>
     Pursuant to the requirements of the Securities Act of 1933 (the "Act"),
as amended, the Registrant, T. Rowe Price OTC Fund, Inc., hereby 
submits this Post-Effective Amendment No. 88 to its Registration Statement,  
*
Form N-1A (SEC File Number 2-12171), pursuant to paragraph (b) of Rule 485
under the Act.  The purpose of this Amendment is to register an additional 
431,717 shares of capital stock of the Fund to be offered under the          
*
currently effective Prospectus dated May 1, 1994 and to furnish the          
*
following:


       EXHIBIT A:    Opinion of Shereff, Friedman, Hoffman & Goodman 
                     as to the legality of the securities being registered.

       EXHIBIT B:    Representation of Henry H. Hopkins (Counsel for the
                     Registrant), as required under Rule 485(b)(3) and (e).


     It is respectfully requested that this Post-Effective Amendment No. 88  
*
become effective immediately upon filing pursuant to paragraph (b) of Rule
485 under the Act.

<PAGE>
     Pursuant to the requirements of the Securities Act of 1933, as amended,
and the Investment Company Act of 1940, as amended, the Registrant certifies
that it meets all of the requirements for effectiveness of this Registration
Statement pursuant to Rule 485(b) under the Securities Act of 1933 and has
duly caused this Registration Statement to be signed on its behalf by the 
undersigned, thereunto duly authorized, in the City of Baltimore, State of
Maryland, this 24th day of February, 1995.                                   
*

                              T. ROWE PRICE OTC FUND, INC.

                              /S/ GREGORY A. McCRICKARD, President

     Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed below by the following persons in
the capacities and on the dates indicated:

      SIGNATURE                     TITLE                   DATE

/S/        GREGORY A McCRICKARD  President               February 24, 1995   
*

/S/        CARMEN F. DEYESU      Treasurer (Chief
                                 Financial Officer)      February 24, 1995   
*

/S/        LEO C. BAILEY         Director                February 24, 1995   
*

/S/        DONALD W. DICK, JR.   Director                February 24, 1995   
*

/S/        DAVID K. FAGIN        Director                February 24, 1995   
*

/S/        ADDISON LANIER        Director                February 24, 1995   
*

/S/        JOHN H. LAPORTE       Chairman of the Board   February 24, 1995   
*

/S/        JOHN K. MAJOR         Director                February 24, 1995   
*

/S/        HANNE M. MERRIMAN     Director                February 24, 1995   
*

/S/        JAMES S. RIEPE        VP & Director           February 24, 1995   
*

/S/        HUBERT D. VOS         Director                February 24, 1995   
*

/S/        PAUL M. WYTHES        Director                February 24, 1995   
*



     
                                       Exhibit A

                                    February 24, 1995


T. Rowe Price OTC Fund, Inc.
100 East Pratt Street
Baltimore, Maryland 21202

Dear Sirs:

     T. Rowe Price OTC Fund, Inc., a Maryland corporation (the
"Corporation"), is filing with the Securities and Exchange Commission (the
"Commission") on behalf of T. Rowe Price OTC Fund Post-Effective Amendment No.
88 to its Registration Statement under the Securities Act of 1933 (the "Act")
on Form N-1A (Securities Act File No. 2-12171) relating, among other things,
to the registration under the Act of 431,717 additional shares of Capital
Stock, par value ($.01) per share (the "additional shares"), which are to be
offered and sold by the Corporation in the manner and on the terms set forth
in the Prospectus current and effective under the Act at the time of sale. 
411,091 of the additional shares are previously outstanding shares of Capital
Stock, par value ($.01) per share, of the Corporation which were redeemed by
the Corporation during the fiscal year ended December 31, 1994 but have not
previously been used by the Corporation for a reduction pursuant to paragraph
(a) of Rule 24e-2 under the Investment Company Act of 1940 (the "1940 Act")
during the current year or pursuant to paragraph (c) of Rule 24f-2 under the
1940 Act in all previous filings during the current year.

     We have, as counsel, participated in various corporate and other
proceedings relating to the Corporation and to the  proposed issuance of the
additional shares.  We have examined copies, either certified or otherwise
proven to our satisfaction to be genuine, of its Charter and By-Laws, as
currently in effect, and a certificate dated February 16, 1995 issued by the
Department of Assessments and Taxation of the State of Maryland, certifying
the existence and good standing of the Corporation.  We have also reviewed the
Post-Effective Amendment No. 88 on Form N-1A being filed by the Corporation,
and are generally familiar with the corporate affairs of the Corporation.

     Based upon the foregoing, it is our opinion that:

     A.   The Corporation has been duly organized and is legally existing
under the laws of the State of Maryland.

     B.   The Corporation is authorized to issue two hundred million
(200,000,000) shares of Capital Stock, par value ($.01) per share.  Under
Maryland law, (a) the number of authorized shares may be increased or
decreased by action of the Board of Directors and (b) shares which were issued
and which have subsequently been redeemed by the Corporation are, by virtue of
such redemption, restored to the status of authorized and unissued shares.

     C.   Subject to the effectiveness under the Act of the above-mentioned
Post-Effective Amendment No. 88 upon issuance of the additional shares within
the limits prescribed by the Charter of the Corporation for a consideration of
not less than the par value thereof, and not less than the net asset value
thereof, the additional shares will be legally issued and outstanding and
fully paid and non-assessable.

<PAGE>
     We hereby consent to the filing of this Opinion with the Securities and
Exchange Commission as part of the above-mentioned Post-Effective Amendment to
the Registration Statement, the reference to our firm as counsel in the
prospectus of the Corporation, and to the filing of this Opinion as part of an
application for registration of the Corporation, its Capital Stock, or both,
under the securities law of any state.  In giving this consent we do not admit
that we come within the category of persons whose consent is required under
Section 7 of the Act.

     We are members of the Bar of the State of New York and do not hold
ourselves out as being conversant with the laws of any jurisdiction other than
those of the United States of America and the State of New York.  We note that
we are not licensed to practice law in the State of Maryland, and to the
extent that any opinion herein involves the law of Maryland, such opinion
should be understood to be based solely upon our review of the documents
referred to above, the published statutes of the State of Maryland and, where
applicable, published cases, rules or regulations of regulatory bodies of that
State.


                                 Very truly yours,



                                 /s/ Shereff, Friedman, Hoffman & Goodman







                               Exhibit B
                            February 24, 1995



Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C.  20549


            Re: File Number 2-12171
                T. Rowe Price OTC Fund, Inc.


Gentlemen:

     As Legal Counsel for T. Rowe Price Associates, Inc., I work on various
matters involving the T. Rowe Price OTC Fund, Inc. ("Registrant") and, in this
connection, have read and reviewed Post-Effective Amendment No. 88 to the
Registrant's Registration Statement, Form N-1A (SEC File Number 2-12171). 

     In accordance with the provisions of paragraphs (b)(3) and (e) of Rule
485
under the Securities Act of 1933, as amended, I hereby represent that (i) no
material event requiring disclosure in the Registrant's Prospectus, other than
the one listed in paragraph (b)(1) of Rule 485, has occurred since the
effective
date of the Registrant's most recent Post-Effective Amendment No. 87 and (ii)
Post-Effective Amendment No. 88 does not contain any disclosures which would
render such Amendment ineligible to become effective pursuant to paragraph (b)
of Rule 485.

                                    Sincerely,



                                    /s/ HENRY H. HOPKINS



<TABLE> <S> <C>


<ARTICLE> 6
<CIK> 0000075170
<NAME> T. ROWE PRICE OTC FUND, INC.
<SERIES>
   <NUMBER> 1
   <NAME> T. ROWE PRICE OTC FUND
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1994
<PERIOD-END>                               DEC-31-1994
<INVESTMENTS-AT-COST>                          167,675
<INVESTMENTS-AT-VALUE>                         201,122
<RECEIVABLES>                                    2,068
<ASSETS-OTHER>                                       0
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                 203,190
<PAYABLE-FOR-SECURITIES>                         4,368
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                        2,096
<TOTAL-LIABILITIES>                              6,464
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                       157,450
<SHARES-COMMON-STOCK>                       14,253,441
<SHARES-COMMON-PRIOR>                       13,296,602
<ACCUMULATED-NII-CURRENT>                           85
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                          5,744
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                        33,447
<NET-ASSETS>                                   196,726
<DIVIDEND-INCOME>                                1,720
<INTEREST-INCOME>                                  889
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                   2,141
<NET-INVESTMENT-INCOME>                            468
<REALIZED-GAINS-CURRENT>                        20,036
<APPREC-INCREASE-CURRENT>                     (20,462)
<NET-CHANGE-FROM-OPS>                               42
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                          383
<DISTRIBUTIONS-OF-GAINS>                        19,961
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                          2,284
<NUMBER-OF-SHARES-REDEEMED>                    (2,695)
<SHARES-REINVESTED>                              1,367
<NET-CHANGE-IN-ASSETS>                         (7,883)
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                        5,669
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                            1,534
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                  2,141
<AVERAGE-NET-ASSETS>                           193,302
<PER-SHARE-NAV-BEGIN>                            15.39
<PER-SHARE-NII>                                    .04
<PER-SHARE-GAIN-APPREC>                          (.04)
<PER-SHARE-DIVIDEND>                             (.03)
<PER-SHARE-DISTRIBUTIONS>                       (1.56)
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              13.80
<EXPENSE-RATIO>                                   1.11
<AVG-DEBT-OUTSTANDING>                               0
<AVG-DEBT-PER-SHARE>                                 0
        



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission